PASCONAL NERVENTROPFEN in the Treatment of Nervous Diseases
NCT01125605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 325
Last updated 2015-04-14
Summary
The purpose of this observational study is to give an overview of the use of PASCONAL NERVENTROPFEN in a 2-4 week treatment of nervous diseases, especially sleep disorders due to nervousness.
Conditions
- Nervousness
- Sleep Disorders
Sponsors & Collaborators
-
Pascoe Pharmazeutische Praeparate GmbH
lead INDUSTRY
Principal Investigators
-
Bianka Krick · Pascoe Pharmazeutische Praeparate GmbH
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-10-31
- Completion
- 2010-10-31
Countries
- Germany
More Related Trials
-
A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers
NCT01002625 ·Status: TERMINATED ·Phase: PHASE1
-
Sleep Well Observation Study
NCT05748574 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness
NCT00666575 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia
NCT00426816 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Diphenhydramine Hydrochloride Effects in Subjects With Occasional Sleeplessness
NCT02578186 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Bacopa Monnieri on Working Memory and Cognitive Processing in Student
NCT02931747 ·Status: COMPLETED ·Phase: PHASE1
-
Non-pharmacological Treatment of Insomnia in Nursing Homes.
NCT01091987 ·Status: COMPLETED ·Phase: NA
-
Efficacy of the Marine Based Nutritional Supplement Peptidyss® on Sleep and Anxiety
NCT04983355 ·Status: COMPLETED ·Phase: NA
-
Valerian to Improve Sleep in Patients With Parkinson's Disease
NCT00070928 ·Status: COMPLETED ·Phase: PHASE2
-
Provigil (Modafinil) Study by Taiwan Biotech Co.
NCT00174174 ·Status: COMPLETED ·Phase: NA
-
Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
NCT00177216 ·Status: COMPLETED ·Phase: PHASE4
-
An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)
NCT00102154 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Clinical Trial of De-stress and Focus Capsule in the Management of Stress.
NCT06569849 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
NCT00107796 ·Status: COMPLETED ·Phase: PHASE3
-
A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia
NCT00606697 ·Status: COMPLETED ·Phase: PHASE2
-
Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
NCT00214968 ·Status: COMPLETED ·Phase: PHASE3
-
RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)
NCT06404112 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274
NCT02852395 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers
NCT01092845 ·Status: COMPLETED ·Phase: PHASE1
-
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
NCT00373542 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders
NCT03514732 ·Status: COMPLETED ·Phase: PHASE1
-
Donepezil Treatment for Sleep Apnea Patients
NCT00912457 ·Status: UNKNOWN ·Phase: PHASE4
-
Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
NCT03772314 ·Status: COMPLETED ·Phase: PHASE2
-
Vestipitant 28-day Tolerance Study
NCT00992160 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)
NCT00685269 ·Status: COMPLETED ·Phase: PHASE2